Apr 05, 2017 12:02 pm UTC| Business
HOLLYWOOD, Fla., April 05, 2017 -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq:NVEE), a provider of professional and technical engineering and consulting solutions, announced today that its energy group has...
Alcobra Provides Update on Request for Extraordinary General Meeting
Apr 05, 2017 12:02 pm UTC| Business
Brosh Capital’s Request Does Not Comply With Alcobra’s Articles of Association Company Addresses Brosh Capital’s Misinformed Views TEL AVIV, Israel, April 05, 2017 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging...
Alcobra Provides Update on Request for Extraordinary General Meeting
Apr 05, 2017 12:02 pm UTC| Business
Brosh Capital’s Request Does Not Comply With Alcobra’s Articles of Association Company Addresses Brosh Capital’s Misinformed Views TEL AVIV, Israel, April 05, 2017 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging...
Alcobra Provides Update on Request for Extraordinary General Meeting
Apr 05, 2017 12:02 pm UTC| Business
Brosh Capital’s Request Does Not Comply With Alcobra’s Articles of Association Company Addresses Brosh Capital’s Misinformed Views TEL AVIV, Israel, April 05, 2017 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging...
Apr 05, 2017 12:02 pm UTC| Business
- Late-breaking poster demonstrates that Endocyte’s bi-specific adaptor molecules can mitigate or eliminate cytokine storms - - Potential to meaningfully improve the safety and tolerability of CAR T-cell therapies - ...
Apr 05, 2017 12:02 pm UTC| Business
- Late-breaking poster demonstrates that Endocyte’s bi-specific adaptor molecules can mitigate or eliminate cytokine storms - - Potential to meaningfully improve the safety and tolerability of CAR T-cell therapies - ...
Apr 05, 2017 12:02 pm UTC| Business
- Late-breaking poster demonstrates that Endocyte’s bi-specific adaptor molecules can mitigate or eliminate cytokine storms - - Potential to meaningfully improve the safety and tolerability of CAR T-cell therapies - ...